InsiderClue
Insiders · Profile

Reddoch James F.

EVP & Chief Scientific Officer at Royalty Pharma. Filing since 2 Mar 2021. CIK 0001814872

Company
Date
Role
Action
Shares
Amount
Of holding
RPRX Royalty Pharma plc
28 Sep 2022
EVP & Chief Scientific Officer
Sold, plan not stated
100,000
$4.12M
10.9%
RPRX Royalty Pharma plc
8 Jun 2022
EVP & Chief Scientific Officer
Sold, plan not stated
100,000
$4.16M
9.8%
RPRX Royalty Pharma plc
27 May 2022
EVP & Chief Scientific Officer
Sold, plan not stated
75,000
$3.08M
6.8%
RPRX Royalty Pharma plc
19 May 2022
EVP & Chief Scientific Officer
Sold, plan not stated
75,000
$3.03M
6.4%
RPRX Royalty Pharma plc
26 Jul 2021
EVP, Research & Investments
Sold, plan not stated
17,898
$711.95K
1.5%
RPRX Royalty Pharma plc
14 Jul 2021
EVP, Research & Investments
Sold, plan not stated
2
$84.00
0.0%
RPRX Royalty Pharma plc
13 Jul 2021
EVP, Research & Investments
Sold, plan not stated
17,832
$749.08K
1.5%
RPRX Royalty Pharma plc
12 Jul 2021
EVP, Research & Investments
Sold, plan not stated
100
$4.20K
0.0%
RPRX Royalty Pharma plc
8 Jul 2021
EVP, Research & Investments
Sold, plan not stated
40,655
$1.71M
3.3%
RPRX Royalty Pharma plc
7 Jul 2021
EVP, Research & Investments
Sold, plan not stated
2,192
$92.09K
0.2%
RPRX Royalty Pharma plc
6 Jul 2021
EVP, Research & Investments
Sold, plan not stated
30,270
$1.28M
2.4%
RPRX Royalty Pharma plc
8 Jun 2021
EVP, Research & Investments
Sold, plan not stated
50,000
$2.32M
3.8%
RPRX Royalty Pharma plc
7 Jun 2021
EVP, Research & Investments
Sold, plan not stated
50,000
$2.33M
3.6%
RPRX Royalty Pharma plc
4 Jun 2021
EVP, Research & Investments
Sold, plan not stated
100,000
$4.46M
6.8%
RPRX Royalty Pharma plc
2 Jun 2021
EVP, Research & Investments
Sold, plan not stated
50,000
$2.11M
3.3%
RPRX Royalty Pharma plc
14 Apr 2021
EVP, Research & Investments
Sold, plan not stated
55,714
$2.35M
21.8%
RPRX Royalty Pharma plc
12 Apr 2021
EVP, Research & Investments
Sold, plan not stated
359
$15.19K
0.1%
RPRX Royalty Pharma plc
22 Mar 2021
EVP, Research & Investments
Sold, plan not stated
43,927
$2.03M
14.6%
RPRX Royalty Pharma plc
2 Mar 2021
EVP, Research & Investments
Sold, plan not stated
100,000
$4.69M
25.0%
19 decisions on file.